TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,669 | -50.0% | 41,348 | +48.6% | 0.00% | – |
Q2 2023 | $691,098 | +189.9% | 27,822 | +75.5% | 0.00% | – |
Q1 2023 | $238,369 | +92.7% | 15,849 | +51.6% | 0.00% | – |
Q4 2022 | $123,683 | -56.6% | 10,455 | +21.9% | 0.00% | – |
Q3 2021 | $285,000 | -40.9% | 8,574 | -31.0% | 0.00% | – |
Q2 2021 | $482,000 | -8.4% | 12,421 | +13.9% | 0.00% | – |
Q1 2021 | $526,000 | +49.9% | 10,908 | +61.5% | 0.00% | – |
Q4 2020 | $351,000 | – | 6,754 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |